To date, >100 mutations in NKX2-1 have been described. Most NKX2-1 mutations are assumed to result in brain-lung-thyroid syndrome through haploinsufficiency, and only five NKX2-1 mutations with dominant-negative effects have been reported so far. In this case report, an additional patient with brain-lung-thyroid syndrome is reported, carrying a novel heterozygous mutation, c.533G>C (p.R178P), in the homeobox of NKX2-1. This mutation has been proven to be a dominant-negative mutation by an in vitro functional assay. Of note, the dominant-negative effect of R178P-NKX2-1 was shown only in the presence of PAX8.
Get full access to this article
View all access options for this article.
References
1.
ProvenzanoC, VenezianoL, AppletonR, FrontaliM, CivitarealeD. 2008. Functional characterization of a novel mutation in TITF-1 in a patient with benign hereditary chorea. J Neurol Sci, 264:56–62.
2.
NettoreIC, MirraP, FerraraAM, SibilioA, PagliaraV, KayCS, LorenzoniPJ, WerneckLC, BruckI, Dos SantosLH, BeguinotF, SalvatoreD, UngaroP, FenziG, ScolaRH, MacchiaPE. 2013. Identification and functional characterization of a novel mutation in the NKX2-1 gene: comparison with the data in the literature. Thyroid, 23:675–682.
3.
CarréA, SzinnaiG, CastanetM, Sura-TruebaS, TronE, Broutin-L'HermiteI, BaratP, GoizetC, LacombeD, MoutardML, RaybaudC, Raynaud-RavniC, RomanaS, YthierH, LegerJ, PolakM. 2009. Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. Hum Mol Genet, 18:2266–2276.
4.
MaquetE, CostagliolaS, ParmaJ, Christophe-HobertusC, OlignyLL, FournetJC, RobitailleY, VuissozJM, PayotA, LabergeS, VassartG, Van VlietG, DeladoeyJ. 2009. Lethal respiratory failure and mild primary hypothyroidism in a term girl with a de novo heterozygous mutation in the NKX2-1/NKX2.1 gene. J Clin Endocrinol Metab, 94:197–203.
5.
GuillotL, CarréA, SzinnaiG, CastanetM, TronE, JaubertF, BroutinI, CounilF, FeldmannD, ClementA, PolakM, EpaudR. 2010. NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “Brain-Lung-Thyroid Syndrome.”. Hum Mutat, 31: 1146–1162.
6.
MoyaCM, Perez de NanclaresG, CastanoL, PotauN, BilbaoJR, CarrascosaA, BargadaM, CoyaR, MartulP, Vicens-CalvetE, SantistebanP. 2006. Functional study of a novel single deletion in the NKX2-1/NKX2.1 homeobox gene that produces congenital hypothyroidism and benign chorea but not pulmonary distress. J Clin Endocrinol Metab, 91:1832–1841.
